LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.
Sang CN; Ramadan NM; Wallihan RG; Chappell AS; Freitag FG; Smith TR; Silberstein SD; Johnson KW; Phebus LA; Bleakman D; Ornstein PL; Arnold B; Tepper SJ; Vandenhende F; Cephalalgia: An International Journal Of Headache, 2004, vol. 24, issue 7, p 596, ISSN 03331024. ISBN 03331024.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef